AccurEdit Therapeutics
PrivateLast Round
Series A
Sep 1, 2025
Est. Valuation
$147M
Total Funding Raised
$116M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AccurEdit Therapeutics is a biotechnology company that develops in vivo gene editing therapies and delivery technologies for the treatment of severe or life-threatening genetic and acquired diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AccurEdit Therapeutics Comparables
Compare AccurEdit Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shape Therapeutics | 84% | |
| AIRNA | 81% | |
| Frequency Therapeutics | 79% | |
AccurEdit Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 1, 2025 | ||||
| Seed | Sep 1, 2021 |
AccurEdit Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cormorant Asset Management | Seed |
| Legend Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased to 71, 592% of headcount.
- Sep 1, 2025
$75M round led by China Medical System Holdings Limited.
AccurEdit Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AccurEdit Therapeutics's valuation, stock price, and market status.